Zacks Small Cap Research on MSN
COCP: Fast track designation for CDI-988 for norovirus infection treatment and prevention
By David Bautz, PhD NASDAQ: COCP READ THE FULL COCP RESEARCH REPORT Business Update Fast Track Designation for CDI-988 On April 2, 2026, Cocrystal Pharma, Inc. (NASDAQ: COCP) announced that the U.S.
Rotavirus, a highly contagious intestinal virus, has been detected in high concentrations in five California areas.
A CDC-coordinated care model improved HCV testing, treatment rates, and time to therapy, supporting scalable strategies for HCV elimination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results